EGFR and cancer: Since the EGF/EGFR signaling is down-regulated in the GEM-R cancer cells that were treated with DON, the enrichment of the EGF-like domain proteins in the exosome may suggest a discharge or re-routing of these proteins to extracellular regions during the glycosylation process possibly due to the disruption of the glycan synthesis pathway.